Susquehanna International Group, LLP Morphic Holding, Inc. Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	BUY	$26.12 - $34.07 $60,076 - $78,361	2,300 Added 1.93%	121,200 $4.13 Million
Q1 2024 May 07, 2024	BUY	$26.64 - $40.31 $2.82 Million - $4.27 Million	106,000 Added 821.71%	118,900 $4.19 Million
Q4 2023 Feb 14, 2024	SELL	$19.95 - $31.0 $414,960 - $644,800	-20,800 Reduced 61.72%	12,900 $372,000
Q3 2023 Nov 14, 2023	SELL	$21.33 - $59.42 $317,817 - $885,358	-14,900 Reduced 30.66%	33,700 $772,000
Q2 2023 Aug 11, 2023	SELL	$34.33 - $62.11 $556,146 - $1.01 Million	-16,200 Reduced 25.0%	48,600 $2.79 Million
Q1 2023 May 16, 2023	BUY	$26.01 - $48.69 $1.69 Million - $3.16 Million	64,800 New	64,800 $2.44 Million

4.71M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.